Cellomics Technology
Cellomics Technology LLC: A biotech firm specializing in lentivirus production and gene manipulation.
Founded
2011Cellomics Technology LLC: A biotech firm specializing in lentivirus production and gene manipulation.
Founded with a mission to advance gene engineering, Cellomics Technology LLC is a biotechnology company specializing in lentivirus production, gene targeting, stable cell line generation, gene cloning, and DNA mutagenesis. The company is dedicated to developing innovative tools for mammalian cell gene engineering, including gene knockout, knockdown, and overexpression. Their products and custom services cater to both somatic and stem cell genetic engineering, aiming to accelerate research in these fields.
Cellomics Technology has garnered attention for its scientific excellence and impactful contributions to biotechnology. The company collaborates with leading researchers and institutions to push the boundaries of genetic engineering. Notable achievements include the development of highly effective lentiviral vectors for gene delivery into hard-to-transfect cells like T cells and neurons. Through these advancements, Cellomics Technology is significantly impacting the field of genetic research and therapy.
Companies similar to Cellomics Technology include Vector Biomed, ExpressCells, PackGene Biotech and OpenCell Technologies.
Cellomics Technology was founded in 2011.
Cellomics Technology's headquarters is located in Baltimore, MD, US.
Cellomics Technology's most recent funding round was for $150k (USD) in April 2012.
As of Apr 12, 2012, Cellomics Technology has disclosed funding of $150k (USD). Undisclosed round amounts are excluded.
Cellomics Technology has 3 employees as of Feb 5, 2024.
OpenCell Technologies
